Delivery Order SPE2DB25D9320-SPE2DB26FWEYG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on August 14, 2025, with an ultimate completion date of September 5, 2025, carries a firm fixed-price arrangement with no set-aside designation. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $33,168.26 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, was awarded without a set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $82,920.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90mg/mL syringes. This firm fixed-price delivery order, issued on October 24, 2025, represents one of numerous pharmaceutical supply orders placed with DMS Pharmaceutical Group under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V)...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award was made on September 10, 2025, with an ultimate completion date of October 1, 2025. This delivery order carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on a competitive basis leveraging its established...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $97,499.70 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract type with an ultimate completion date of July 9, 2025. The award was made without a set-aside designation, allowing the vendor to compete directly in the federal pharmaceutical...
- The Defense Logistics Agency awarded a $387,704.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on September 27, 2025, with an ultimate completion date of October 20, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The delivery order was issued on September 17, 2025, with an ultimate completion date of October 8, 2025, under a firm fixed-price contract structure. This award represents no set-aside designation and reflects DMS Pharmaceutical Group's competitive standing...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility with an ultimate completion date of October 9, 2025. The contract employs firm fixed-price pricing with no set-aside designation, allowing the vendor to compete...
- SPE2DB25D9320Indefinite Delivery Contract
- SPE2DB25D9320-SPE2DB26FWEYGDelivery Order
The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The delivery order, issued on October 28, 2025, with an ultimate completion date of November 19, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award was issued under DMS Pharmaceutical Group's recently established Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy designed to support recurring medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a portfolio encompassing branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals. The company's IDC with the Defense Logistics Agency carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. This delivery order for Stelara, an immunosuppressant biologic used in the treatment of autoimmune conditions, exemplifies the company's role in fulfilling the specialized pharmaceutical requirements of the military medical system across multiple therapeutic categories and product lines.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 10/28/25 |